Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Fentanyl Citrate Injection
Status: Currently in Shortage
»Date first posted:
01/01/2012
»Therapeutic Categories: Analgesia/Addiction; Pediatric
Fresenius Kabi USA, LLC (Revised 04/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Unavailable | Next release May 2026. Check wholesalers for inventory. | Demand increase for the drug |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Unavailable | Next release May 2026. Check wholesalers for inventory. | Other |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Unavailable | Next release May 2026. Check wholesalers for inventory. | Other |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Unavailable | Next release May 2026. Check wholesalers for inventory. | Other |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Unavailable | Next release not available at this time. Check wholesalers for inventory. | Other |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Available | Check wholesalers for inventory |
Hikma Pharmaceuticals USA, Inc. (Revised 03/12/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Unavailable | Inventory available in vial presentations. | Other |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Unavailable | Inventory available in vial presentations. | Other |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Unavailable | Inventory available in vial presentations. | Other |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Unavailable | Additional lots will be available in the April 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Reverified 04/22/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Available | ||
| Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Unavailable | Next Delivery: April 2026; Estimated Recovery: June 2026 | Demand increase for the drug |
| Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Available | ||
| Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: June 2026; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Available |